Showing results (2051-2060 of 4,531) with videos related to

Sort By:
Pageof 454
Neurourology and Urodynamics|August 19, 2020
Brain functional network alterations caused by a strong desire to void in healthy adults: a graph theory analysis studyDongqing Pang, Yi Gao, Limin Liao, et al.
Neurourology and Urodynamics|January 27, 2015
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?Shachar Aharony, Ornella Lam, Yves Lapierre, et al.
Neurourology and Urodynamics|January 27, 2015
Clinical and ultrasonographic study of patients presenting with transvaginal mesh complicationsJittima Manonai, Ghazaleh Rostaminia, Lindsay Denson, et al.
Neurourology and Urodynamics|January 27, 2015
Prevalence and triage of first contact pelvic floor dysfunction complaints in male patients referred to a Pelvic Care CentreBary Berghmans, Fred Nieman, C Leue, et al.
Neurourology and Urodynamics|July 29, 2020
Outcomes of transurethral resection of the prostate in unobstructed patients with concomitant detrusor underactivityEmanuele Rubilotta, Matteo Balzarro, Marilena Gubbiotti, et al.
Neurourology and Urodynamics|February 10, 2015
Development and psychometric evaluation of the ICIQ-LTCqol: A self-report quality of life questionnaire for long-term indwelling catheter usersNikki Cotterill, Sarah Fowler, Miriam Avery, et al.
Neurourology and Urodynamics|February 10, 2015
Retropubic bulbourethral sling in incontinence post-exstrophy repair: 2-year minimal follow up of a salvage procedureBassem S Wadie, Tamer E Helmy, Mohamed E Dawaba, et al.
Neurourology and Urodynamics|March 19, 2015
An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SFKarin S Coyne, Christine L Thompson, Jin-Shei Lai, et al.
Neurourology and Urodynamics|February 24, 2015
Effects of the phosphodiesterase 5 inhibitor Tadalafil on bladder function in a rat model of partial bladder outlet obstructionYuko Kawai, Michiko Oka, Ryohei Yoshinaga, et al.
Neurourology and Urodynamics|September 25, 2012
Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiariesW Stuart Reynolds, Karen P Gold, Shenghua Ni, et al.
Pageof 454